Release Date: 30/10/20 08:49 Summary: Entitlement Offer - Updated Timetable Price Sensitive: Yes Download Document 29.68KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%